D. Boral Capital Initiates Coverage On Medicus Pharma with Buy Rating, Announces Price Target of $14

Benzinga · 04/14 11:24
D. Boral Capital analyst Jason Kolbert initiates coverage on Medicus Pharma (NASDAQ:MDCX) with a Buy rating and announces Price Target of $14.